{
  "ticker": "BMY",
  "year": 2025,
  "quarter": 1,
  "last_updated": "2025-04-19T09:55:23.615356",
  "count": 21,
  "transactions": [
    {
      "id": 351393,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Poole Ahn Amanda",
      "reporting_owner_cik": "0002005210",
      "reporting_owner_position": "EVP, Chief People Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "690",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "3114"
    },
    {
      "id": 351397,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "LEUNG SANDRA",
      "reporting_owner_cik": "0001199294",
      "reporting_owner_position": "EVP, General Counsel",
      "transaction_date": "2025-03-10",
      "transaction_shares": "5858",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "353243.333"
    },
    {
      "id": 351398,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2025-03-10",
      "transaction_shares": "4886",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "68818.486"
    },
    {
      "id": 351404,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Holzer Phil M",
      "reporting_owner_cik": "0002012588",
      "reporting_owner_position": "SVP and Controller",
      "transaction_date": "2025-03-10",
      "transaction_shares": "701",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "12461"
    },
    {
      "id": 351410,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Lenkowsky Adam",
      "reporting_owner_cik": "0001975719",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "1904",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "8554"
    },
    {
      "id": 351412,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Elkins David V",
      "reporting_owner_cik": "0001451604",
      "reporting_owner_position": "EVP, Chief Financial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "8045",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "203013"
    },
    {
      "id": 351422,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2025-03-10",
      "transaction_shares": "2836",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "9832"
    },
    {
      "id": 351427,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Plenge Robert M",
      "reporting_owner_cik": "0001773367",
      "reporting_owner_position": "EVP, Chief Research Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "1165",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "12480"
    },
    {
      "id": 351436,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Shanahan Karin",
      "reporting_owner_cik": "0001917325",
      "reporting_owner_position": "EVP, Glob. Prod. Dev. & Supply",
      "transaction_date": "2025-03-10",
      "transaction_shares": "2447",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7783"
    },
    {
      "id": 351440,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "6985",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "111611"
    },
    {
      "id": 351448,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hoch Lynelle",
      "reporting_owner_cik": "0002005382",
      "reporting_owner_position": "President, Cell Therapy Org.",
      "transaction_date": "2025-03-10",
      "transaction_shares": "546",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2272"
    },
    {
      "id": 351462,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Gallman Cari",
      "reporting_owner_cik": "0001995058",
      "reporting_owner_position": "EVP, Corporate Affairs",
      "transaction_date": "2025-03-10",
      "transaction_shares": "349",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "5368"
    },
    {
      "id": 351460,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hickey Benjamin",
      "reporting_owner_cik": "0001753055",
      "reporting_owner_position": "President, RayzeBio Org.",
      "transaction_date": "2025-03-01",
      "transaction_shares": "3286",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10419"
    },
    {
      "id": 305699,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2025-02-20",
      "transaction_shares": "2000",
      "transaction_price": "55.048",
      "transaction_type": "P",
      "shares_after_transaction": "104626"
    },
    {
      "id": 351476,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "BOERNER CHRISTOPHER S.",
      "reporting_owner_cik": "0001543747",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2025-02-20",
      "transaction_shares": "2000",
      "transaction_price": "55.048",
      "transaction_type": "P",
      "shares_after_transaction": "104626"
    },
    {
      "id": 305682,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2025-02-14",
      "transaction_shares": "1823.486",
      "transaction_price": "54.84",
      "transaction_type": "P",
      "shares_after_transaction": "63932.486"
    },
    {
      "id": 351457,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hirawat Samit",
      "reporting_owner_cik": "0001781290",
      "reporting_owner_position": "EVP,Chief Med.Offr.,Drug Dev.",
      "transaction_date": "2025-02-14",
      "transaction_shares": "1823.486",
      "transaction_price": "54.84",
      "transaction_type": "P",
      "shares_after_transaction": "63932.486"
    },
    {
      "id": 305633,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2025-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7829"
    },
    {
      "id": 305692,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hickey Benjamin",
      "reporting_owner_cik": "0001753055",
      "reporting_owner_position": "President, RayzeBio Org.",
      "transaction_date": "2025-02-01",
      "transaction_shares": "10078",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10858"
    },
    {
      "id": 351391,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Meyers Gregory Scott",
      "reporting_owner_cik": "0001908769",
      "reporting_owner_position": "EVP, Chief Digital & Tech Off.",
      "transaction_date": "2025-02-01",
      "transaction_shares": "2543",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "7829"
    },
    {
      "id": 351469,
      "issuer_name": "BRISTOL MYERS SQUIBB CO",
      "reporting_owner": "Hickey Benjamin",
      "reporting_owner_cik": "0001753055",
      "reporting_owner_position": "President, RayzeBio Org.",
      "transaction_date": "2025-02-01",
      "transaction_shares": "10078",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "10858"
    }
  ]
}